Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Moberg Pharma AB (publ) (MB8.F)

0.6740
-0.0105
(-1.53%)
At close: April 25 at 8:06:40 AM GMT+2

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

33.8

Severe

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
5IU.F Isofol Medical AB N 34 -- -- --
NK9.SG Neuren Pharmaceuticals Ltd. 34 -- -- --
MB8.F Moberg Pharma AB A 34 -- -- --
2E40.SG PHAXIAM Therapeutics S.A. 34 -- -- --
AMLX Amylyx Pharmaceuticals, Inc. 34 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 4/2025
MB8.F
Category Average
N/A None Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No